ClinicalTrials.gov
ClinicalTrials.gov Menu

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00134680
Recruitment Status : Completed
First Posted : August 25, 2005
Last Update Posted : September 16, 2014
Sponsor:
Collaborators:
Genentech, Inc.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Duke University